Insider · CIK 0001145910

YERXA BENJAMIN R

Reports to the SEC for 3 companies · DURHAM, NC

sec.gov

Transactions

Companies

Filings

CIK

0001145910

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-23	IRDOpus Genetics, Inc.S Sale	Director, President	SSale	−7,429 sh	$2.97	−$22.1K	704,106
2026-04-23	IRDOpus Genetics, Inc.S Sale	Director, President	SSale	−7,470 sh	$5.24	−$39.1K	711,535
2026-01-22	IRDOpus Genetics, Inc.A Award	Director, President	AAward	+400K sh	—	—	719,005
2025-10-22	IRDOpus Genetics, Inc.F Tax Payment	Director, President	FTax Payment	−23.8K sh	$1.95	−$46.4K	319,005
2024-11-21	IRDOpus Genetics, Inc.P Purchase	Director, President	PPurchase	+10K sh	$0.98	+$9,834	342,800
2024-11-07	IRDOpus Genetics, Inc.A Award	Director, President	AAward	+333K sh	—	—	332,800
2024-06-20	CLSDQClearside Biomedical, Inc. · Stock Option (right to buy)A Award	Director	AAward	+45K sh	—	—	45,000
2024-05-15	CLSDQClearside Biomedical, Inc.P Purchase	Director	PPurchase	+7,813 sh	$1.31	+$10.2K	17,957
2023-06-22	CLSDQClearside Biomedical, Inc. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2022-06-22	CLSDQClearside Biomedical, Inc. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2022-03-02	CLSDQClearside Biomedical, Inc. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2010-05-12	INSPIRE PHARMACEUTICALS INCStock Option (Right to Buy)A Award	EVP & Chf, Research & Develop	AAward	+17.5K sh	—	—	17,500
2010-05-12	INSPIRE PHARMACEUTICALS INCRestricted Stock UnitsA Award	EVP & Chf, Research & Develop	AAward	+1,750 sh	—	—	1,750
2010-05-03	INSPIRE PHARMACEUTICALS INCS Sale	EVP & Chf, Research & Develop	SSale	−100 sh	$6.82	−$682	54,157
2010-05-03	INSPIRE PHARMACEUTICALS INCS Sale	EVP & Chf, Research & Develop	SSale	−100 sh	$6.80	−$680	54,057
2010-05-03	INSPIRE PHARMACEUTICALS INCS Sale	EVP & Chf, Research & Develop	SSale	−39 sh	$6.79	−$264.81	54,018
2010-05-03	INSPIRE PHARMACEUTICALS INCS Sale	EVP & Chf, Research & Develop	SSale	−161 sh	$6.78	−$1,091.58	53,857
2010-05-03	INSPIRE PHARMACEUTICALS INCS Sale	EVP & Chf, Research & Develop	SSale	−300 sh	$6.77	−$2,031	53,557
2010-05-03	INSPIRE PHARMACEUTICALS INCS Sale	EVP & Chf, Research & Develop	SSale	−100 sh	$6.76	−$676	53,457
2010-05-03	INSPIRE PHARMACEUTICALS INCS Sale	EVP & Chf, Research & Develop	SSale	−200 sh	$6.75	−$1,350	53,257
2010-05-03	INSPIRE PHARMACEUTICALS INCS Sale	EVP & Chf, Research & Develop	SSale	−571 sh	$6.70	−$3,825.7	52,686
2010-05-03	INSPIRE PHARMACEUTICALS INCS Sale	EVP & Chf, Research & Develop	SSale	−429 sh	$6.69	−$2,870.01	52,257
2010-04-01	INSPIRE PHARMACEUTICALS INCS Sale	EVP & Chf, Research & Develop	SSale	−721 sh	$6.33	−$4,563.93	55,536
2010-04-01	INSPIRE PHARMACEUTICALS INCS Sale	EVP & Chf, Research & Develop	SSale	−200 sh	$6.32	−$1,264	55,336
2010-04-01	INSPIRE PHARMACEUTICALS INCS Sale	EVP & Chf, Research & Develop	SSale	−260 sh	$6.31	−$1,640.6	55,076
2010-04-01	INSPIRE PHARMACEUTICALS INCS Sale	EVP & Chf, Research & Develop	SSale	−300 sh	$6.30	−$1,890	54,776
2010-04-01	INSPIRE PHARMACEUTICALS INCS Sale	EVP & Chf, Research & Develop	SSale	−519 sh	$6.25	−$3,243.75	54,257
2010-03-18	INSPIRE PHARMACEUTICALS INCStock Option (Right to Buy)A Award	EVP & Chf, Research & Develop	AAward	+17.5K sh	—	—	17,500
2010-03-18	INSPIRE PHARMACEUTICALS INCRestricted Stock UnitsA Award	EVP & Chf, Research & Develop	AAward	+1,750 sh	—	—	1,750
2010-03-01	INSPIRE PHARMACEUTICALS INCS Sale	EVP & Chf, Research & Develop	SSale	−496 sh	$6.16	−$3,055.36	57,761
2010-03-01	INSPIRE PHARMACEUTICALS INCS Sale	EVP & Chf, Research & Develop	SSale	−604 sh	$6.15	−$3,714.6	57,157
2010-03-01	INSPIRE PHARMACEUTICALS INCS Sale	EVP & Chf, Research & Develop	SSale	−100 sh	$6.14	−$614	57,057
2010-03-01	INSPIRE PHARMACEUTICALS INCS Sale	EVP & Chf, Research & Develop	SSale	−576 sh	$6.13	−$3,530.88	56,481
2010-03-01	INSPIRE PHARMACEUTICALS INCS Sale	EVP & Chf, Research & Develop	SSale	−100 sh	$6.11	−$611	56,381
2010-03-01	INSPIRE PHARMACEUTICALS INCS Sale	EVP & Chf, Research & Develop	SSale	−124 sh	$6.10	−$756.4	56,257
2010-02-01	INSPIRE PHARMACEUTICALS INCS Sale	EVP & Chf, Research & Develop	SSale	−200 sh	$5.46	−$1,092	60,057
2010-02-01	INSPIRE PHARMACEUTICALS INCS Sale	EVP & Chf, Research & Develop	SSale	−100 sh	$5.44	−$544	59,957
2010-02-01	INSPIRE PHARMACEUTICALS INCS Sale	EVP & Chf, Research & Develop	SSale	−45 sh	$5.43	−$244.35	59,912
2010-02-01	INSPIRE PHARMACEUTICALS INCS Sale	EVP & Chf, Research & Develop	SSale	−455 sh	$5.41	−$2,461.55	59,457
2010-02-01	INSPIRE PHARMACEUTICALS INCS Sale	EVP & Chf, Research & Develop	SSale	−1,200 sh	$5.40	−$6,480	58,257
2010-01-04	INSPIRE PHARMACEUTICALS INCS Sale	EVP & Chf, Research & Develop	SSale	−400 sh	$5.62	−$2,248	61,857
2010-01-04	INSPIRE PHARMACEUTICALS INCS Sale	EVP & Chf, Research & Develop	SSale	−1,100 sh	$5.61	−$6,171	60,757
2010-01-04	INSPIRE PHARMACEUTICALS INCS Sale	EVP & Chf, Research & Develop	SSale	−200 sh	$5.60	−$1,120	60,557
2010-01-04	INSPIRE PHARMACEUTICALS INCS Sale	EVP & Chf, Research & Develop	SSale	−106 sh	$5.59	−$592.54	60,451
2010-01-04	INSPIRE PHARMACEUTICALS INCS Sale	EVP & Chf, Research & Develop	SSale	−94 sh	$5.58	−$524.52	60,357
2010-01-04	INSPIRE PHARMACEUTICALS INCS Sale	EVP & Chf, Research & Develop	SSale	−100 sh	$5.55	−$555	60,257
2009-12-01	INSPIRE PHARMACEUTICALS INCS Sale	EVP & Chf, Research & Develop	SSale	−168 sh	$5.76	−$967.68	64,089
2009-12-01	INSPIRE PHARMACEUTICALS INCS Sale	EVP & Chf, Research & Develop	SSale	−50 sh	$5.74	−$287	64,039
2009-12-01	INSPIRE PHARMACEUTICALS INCS Sale	EVP & Chf, Research & Develop	SSale	−100 sh	$5.73	−$573	63,939
2009-12-01	INSPIRE PHARMACEUTICALS INCS Sale	EVP & Chf, Research & Develop	SSale	−300 sh	$5.72	−$1,716	63,639

Recent filings

Accepted (ET)
Jul 274
YERXA BENJAMIN R0000905148-26-003354
SEC(opens sec.gov)
Apr 274
YERXA BENJAMIN R0000905148-26-001867
SEC(opens sec.gov)
Jan 264
YERXA BENJAMIN R0000905148-26-000359
SEC(opens sec.gov)
Oct 244
YERXA BENJAMIN R0000905148-25-003670
SEC(opens sec.gov)
Nov 254
YERXA BENJAMIN R0000905148-24-003268
SEC(opens sec.gov)
Nov 124
YERXA BENJAMIN R0000905148-24-003015
SEC(opens sec.gov)
Jun 214
YERXA BENJAMIN R0001415889-24-017826
SEC(opens sec.gov)
May 154
YERXA BENJAMIN R0001415889-24-013248
SEC(opens sec.gov)
Jun 234
YERXA BENJAMIN R0001209191-23-039416
SEC(opens sec.gov)
Jun 244
YERXA BENJAMIN R0001209191-22-039237
SEC(opens sec.gov)
Mar 44
YERXA BENJAMIN R0001209191-22-016390
SEC(opens sec.gov)
May 134
YERXA BENJAMIN R0001181431-10-026581
SEC(opens sec.gov)
May 54
YERXA BENJAMIN R0001181431-10-024501
SEC(opens sec.gov)

Companies

Address

C/O OPUS GENETICS, INC. 8 DAVIS DRIVE, SUITE 220

DURHAM, NC, 27713